Insights & Ideas
AI insights, tutorials, and updates for every profession.
Humanoid Robots Are Leaving the Demo Stage
Humanoid robots are not mainstream yet. But funding rounds, deployment contracts, manufacturing capacity targets, and production timelines are starting to look industrial rather than experimental. Apptronik raised $935 million, Boston Dynamics began Atlas production with all 2026 units committed, UBTech rolled its 1,000th unit, and Xpeng broke ground on a mass production facility. Here is what changed and what remains hard.
Physical AI Is the New Cloud: Why Robots Are the Next Platform
Cloud AI was phase one — chatbots, code assistants, search engines running on GPU clusters in data centers. Phase two is physical AI: intelligence embedded in machines that sense, move, and act in the real world. Arm created a dedicated Physical AI division, NVIDIA declared the ChatGPT moment for robotics, and Goldman Sachs revised its humanoid robot forecast sixfold. Here is the stack, the players, and the adoption timeline.
Government AI Goes Mainstream: Why Public-Sector Automation Is Heating Up
Government AI used to sound like a pilot program. In 2026, it increasingly sounds like policy, procurement, and national infrastructure.
Marketing Without a Marketing Team: The 2026 State of AI Advertising
AI is not just helping marketers work faster. It is changing how many people a serious marketing machine actually needs.
Shopping Agents Are Rewriting the Customer Journey
The next big ecommerce shift may not happen on your website. It may happen inside someone else's AI assistant.
The AI Classroom Has Arrived — Now the Real Debate Begins
Schools are past the point where AI can be treated like a passing distraction. The real fight now is over how it gets normalized.
General AI vs Domain AI: Why Specialized Models Are Winning in Education
In education, the question is no longer whether AI belongs in the classroom. It is which kind of AI belongs there, and on whose terms.
Pharma's New Lab Partner: How AI Is Compressing Drug Discovery
AI will not magically fix drug discovery. But it is already compressing some of the slowest and most expensive steps in the pipeline.
AI in Healthcare Is Moving From Note-Taking to Clinical Workflow
Healthcare AI is graduating from ambient scribes to full workflow systems — spanning scheduling, coding, chart prep, care coordination, and clinical decision support. The companies that win will be workflow-native, not feature-native.